Skip to main content

Table 5 Mortality at 30 days and end of follow-up following respiratory hospitalizations, ICU hospitalizations, and ICU hospializations with and without mechanical ventilation

From: Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

 

Untreated

Treated

Statistical Analysis

All respiratory hospitalizations

N = 402

N = 402

 

30 day mortality, total (%)

40 (10.0)

41 (10.2)

HR 0.96 (CI 0.70–1.33), p = 0.812

End of follow-up mortality, total (%)

192 (47.8)

81 (20.1)

HR 0.59 (CI 0.45–0.77), p < 0.001

Months of follow-up mean(SD)

10.6 (12.1) Median: 5.3

6.3 (8.9) Median: 2.2

 

ICU hospitalizations

N = 274

N = 274

 

30 day mortality, total (%)

45 (16.4)

49 (17.9)

HR 1.05 (CI 0.71–1.58) p = 0.782

End of follow-up mortality, total (%)

140 (51.1)

102 (37.2)

HR 0.79 (CI 0.61–1.02) p = 0.075

Months of follow-up mean (SD)

8.7 (11.5) Median: 3.1

7.2 (10.4) Median: 2.4

 

ICU Hospitalizations w/all mechanical ventilation

N = 94

N = 94

 

30 day mortality, total (%)

29 (30.9)

27 (28.7)

HR 0.91 (CI 0.52–1.59) p = 0.734

End of follow-up mortality, total (%)

66 (70.2)

50 (53.2)

HR 0.64 (CI 0.43–0.94) p = 0.021

Months of Follow-up mean (SD)

6.3 (10.7) Median: 1.18

4.1 (6.2) Median: 1.55

 

ICU hospitalizations w/non-invasive mechanical ventilation

N = 60

N = 60

 

30 day mortality, total (%)

13 (21.7)

13 (21.7)

HR 0.94 (CI 0.34–2.57) p = 0.907

End of follow-up mortality, tota l(%)

39 (65.0)

26 (43.3)

HR 0.80 (CI 0.43–1.47) p = 0.472

Months of Follow-up mean (SD)

7.13 (11.02) Median: 2.37

4.73 (6.71) Median: 1.87

 

ICU hospitalizations w/invasive mechanical ventilation

N = 34

N = 34

 

30 day mortality, total (%)

10 (29.4)

14 (41.2)

HR 1.78 (CI 0.55–5.79) p = 0.339

End of follow-up mortality, total (%)

26 (76.5)

24 (70.6)

HR 1.47 (CI 0.66–3.27) p = 0.345

Months of Follow-up mean (SD)

8.25 (13.95) Median: 1.18

3.03 (5.11) Median: 1.05

 

ICU hospitalizations w/out mechanical ventilation

N = 180

N = 180

 

30 day mortality, total (%)

21 (11.7)

22 (12.2)

HR 1.00 (CI 0.56–1.83) p = 0.980

End of follow-up mortality, total (%)

79 (43.9)

52 (28.9)

HR 0.71 (CI 0.50–1.00) p = 0.055

Months of Follow-up mean (SD)

10.0 (11.5) Median: 5.9

8.8 (11.7) Median: 3.0

Â